Insider · CIK 0001858176

Kemble George

Reports to the SEC for 1 company · FOSTER CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001858176

Forms 4 and 5

Insider transactions

35 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-14	SGMTSagimet Biosciences Inc.M Exercise/Conversion	Director	MExercise/Conversion	+327K sh	$6.36	+$2.08M	388,779
2026-08-14	SGMTSagimet Biosciences Inc.M Exercise/Conversion	Director	MExercise/Conversion	+24.4K sh	$6.36	+$155K	413,148
2026-08-14	SGMTSagimet Biosciences Inc.S Sale	Director	SSale	−351K sh	$10.23	−$3.59M	62,161
2026-08-14	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−327K sh	—	—	31,455
2026-08-14	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−24.4K sh	—	—	11,608
2026-08-11	SGMTSagimet Biosciences Inc.M Exercise/Conversion	Director	MExercise/Conversion	+9,751 sh	$6.36	+$62K	71,912
2026-08-11	SGMTSagimet Biosciences Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10.5K sh	$6.36	+$66.5K	82,367
2026-08-11	SGMTSagimet Biosciences Inc.S Sale	Director	SSale	−20.2K sh	$9.95	−$201K	62,161
2026-08-11	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,751 sh	—	—	358,073
2026-08-11	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10.5K sh	—	—	35,977
2026-07-20	SGMTSagimet Biosciences Inc.S Sale	Director	SSale	−18.8K sh	$7.46	−$141K	62,161
2026-06-12	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+39.6K sh	—	—	39,567
2025-11-20	SGMTSagimet Biosciences Inc.S Sale	Director	SSale	−37.7K sh	$7.69	−$290K	81,005
2025-06-09	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+32.3K sh	—	—	32,250
2024-07-23	SGMTSagimet Biosciences Inc.S Sale	Director	SSale	−23.6K sh	$3.17	−$74.8K	118,693
2024-07-19	SGMTSagimet Biosciences Inc.S Sale	Director	SSale	−14.1K sh	$3.10	−$43.6K	142,318
2023-11-17	SGMTSagimet Biosciences Inc.A Award	Director	AAward	+151K sh	—	—	156,380
2023-09-07	SGMTSagimet Biosciences Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,630 sh	$0.79	+$4,447.7	5,630
2023-09-07	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,630 sh	—	—	0
2023-07-18	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,630 sh	—	—	0
2023-07-18	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,630 sh	—	—	5,630
2023-07-18	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,179 sh	—	—	0
2023-07-18	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+3,179 sh	—	—	3,179
2023-07-18	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,147 sh	—	—	0
2023-07-18	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,147 sh	—	—	7,147
2023-07-18	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−26.4K sh	—	—	0
2023-07-18	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+26.4K sh	—	—	26,352
2023-07-18	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−368K sh	—	—	0
2023-07-18	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+368K sh	—	—	367,824
2023-07-18	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−46.4K sh	—	—	0
2023-07-18	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+46.4K sh	—	—	46,432
2023-07-18	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−526K sh	—	—	0
2023-07-18	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+526K sh	—	—	526,332
2023-07-18	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−21.2K sh	—	—	0
2023-07-18	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+21.2K sh	—	—	21,173

Recent filings

Accepted (ET)
Aug 174
Kemble George0001193125-26-354018
SEC(opens sec.gov)
Aug 124
Kemble George0001193125-26-347407
SEC(opens sec.gov)
Jul 224
Kemble George0001193125-26-312386
SEC(opens sec.gov)
Jun 154
Kemble George0001104659-26-074045
SEC(opens sec.gov)
Nov 214
Kemble George0001104659-25-115071
SEC(opens sec.gov)
Jun 104
Kemble George0001104659-25-058223
SEC(opens sec.gov)
Jul 254
Kemble George0001104659-24-082630
SEC(opens sec.gov)
Jul 234
Kemble George0001104659-24-081887
SEC(opens sec.gov)
Nov 214
Kemble George0001104659-23-120374
SEC(opens sec.gov)
Sep 84
Kemble George0001104659-23-099310
SEC(opens sec.gov)
Jul 204
Kemble George0001104659-23-082726
SEC(opens sec.gov)

Companies

Sagimet Biosciences Inc.DirectorSGMT

Address

SAGIMET BIOSCIENCES INC. 950 TOWER LANE, SUITE 1500

FOSTER CITY, CA, 94404